Suicide

AI chatbots raise critical concerns in mental health, revealing risks of suicide ideation, maladaptive thinking, and the need for clinician awareness and intervention.

Socrates’ suicide as an affirmative choice.

Recent research links nighttime screen use and easy medication access to increased suicide attempts among adolescents, highlighting urgent mental health concerns.

Clinicians face challenges in suicide risk assessment, especially with patients denying intent before tragic outcomes. Understanding lethal suicide deniers is crucial.

Oregon's "Create Resilience" Youth Art Contest celebrates creativity in mental health, showcasing powerful youth submissions that inspire hope and connection.

Christine Yu Moutier, MD, discusses suicide prevention strategies, highlighting risk factors and the importance of culturally competent care for vulnerable populations.

Today is World Suicide Prevention Day. Media training emerges as a vital tool for psychiatrists, enhancing suicide prevention efforts and combating misinformation in mental health.

A new mobile app has been found to reduce suicidal behavior post hospitalization in patients at high suicide risk.

NRX-100, a preservative-free ketamine, is granted expanded access for treatment of suicidal ideation in depression, offering new hope for patients.

OpenAI acknowledges ChatGPT's risks to psychiatric patients and commits to improving safety measures, but skepticism about their sincerity remains.

Explore the latest research on athlete mental health, highlighting concussion recovery, anti-doping stress, and the protective role of competitive sports.

AI chatbots pose significant mental health risks, often exacerbating issues like suicide, self-harm, and delusions, highlighting urgent regulatory needs.

NRx Pharmaceuticals secures FDA Fast Track designation for NRX-100, a preservation-free formulation of intravenous ketamine for suicidal ideation in depression.

Youth with neurodevelopmental disorders face significant suicide risks.

The debate over palliative psychiatry's role in advocating for psychiatric euthanasia continues, raising ethical concerns about mental health care and patient autonomy.

The complex ethics of dying, death, and assisted dying lead to debates on terminology and implications for patient autonomy and suffering.

Christine Yu Moutier, MD, the chief medical officer of the AFSP, speaks about the impact of losing LGBTQ+ tailored crisis support via 988, and strategies to better support vulnerable youth.

LGBTQ+ youth face increased suicide risks as vital support services are cut, prompting urgent calls for Congress to reverse this dangerous decision.

There is a critical link between sleep disorders and psychiatric conditions. In this Special Report, examine effective diagnosis and treatment strategies for better patient outcomes.

Effective safety plans are an important measure for suicide prevention. Emphasizing early intervention and structured support can reduce risks and save lives.

Euthanasia risks becoming a symptom of burnout.

Explore the ethical complexities of euthanasia and assisted suicide through a philosophical lens.

NRx Pharmaceuticals secures FDA fee waiver for NRX-100, a preservative-free ketamine aimed at treating suicidal depression, enhancing accessibility for patients.

“Call no man happy before he is dead.”

Exploring the complexities of assisted dying, ethical dilemmas, and the evolving role of physicians in end-of-life decisions.